Literature DB >> 7298109

Plasma norepinephrine during stress in essential hypertension.

D S Goldstein.   

Abstract

Comparative studies of plasma norepinephrine in patients with essential hypertension and in normotensive controls have consistently reported higher mean resting levels of norepinephrine in the hypertensive groups, but the hypertensive-normotensive differences have often been small and, in about three-fifths of the studies, not statistically significant. The author reviewed the medical literature to test the hypothesis that, during stress, hypertensive-normotensive differences in norepinephrine become more apparent. Among 24 studies involving orthostatic stress, the increment in norepinephrine with standing was similar for hypertensives and normotensives (239 vs 230 pg/ml). In contrast, among eight studies involving exercise, the increment in norepinephrine was significantly greater in hypertensives (834 vs 450 pg/ml). For both standing and isotonic exercise, absolute changes in norepinephrine with stress correlated with basal norepinephrine across the hypertensive but not the normotensive groups. These results are consistent with the existence within the hypertensive population of a subgroup of patients with elevated norepinephrine levels at rest and excessive sympathetic responsiveness to stress. However, the available literature is decidedly lacking in studies about other types of stress besides standing and exercise.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298109     DOI: 10.1161/01.hyp.3.5.551

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

Review 2.  Sympathoneural and adrenomedullary responses to mental stress.

Authors:  Jason R Carter; David S Goldstein
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

3.  Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.

Authors:  M G Bianchetti; P Weidmann; C Beretta-Piccoli; U Rupp; K Boehringer; L Link; C Ferrier
Journal:  Br Heart J       Date:  1984-03

4.  Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.

Authors:  D S Goldstein; D Horwitz; H R Keiser; R J Polinsky; I J Kopin
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

5.  Pioneer Award Address: ignorance isn't biased: comments on receiving the Pioneer Award.

Authors:  David S Goldstein
Journal:  Cleve Clin J Med       Date:  2009-04       Impact factor: 2.321

6.  Neuroendocrine mechanisms of acupuncture in the treatment of hypertension.

Authors:  Wei Zhou; John C Longhurst
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-18       Impact factor: 2.629

Review 7.  Hypertension in older adults: Assessment, management, and challenges.

Authors:  Estefania Oliveros; Hena Patel; Stella Kyung; Setri Fugar; Alan Goldberg; Nidhi Madan; Kim A Williams
Journal:  Clin Cardiol       Date:  2019-12-11       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.